Batoclimab ( DrugBank: Batoclimab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
11	重症筋無力症	1
14	慢性炎症性脱髄性多発神経炎／多巣性運動ニューロパチー	1

11. 重症筋無力症

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05403541 (ClinicalTrials.gov)	June 27, 2022	26/5/2022	Phase 3 Study to Assess the Efficacy and Safety of Batoclimabas Induction and Maintenance Therapy in ...	A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficac ...	Generalized Myasthenia Gravis	Drug: Batoclimab680 mg SC weekly;Drug: Batoclimab340 mg SC weekly;Drug: Matching Placebo SC;Drug: Ba ...	Immunovant Sciences GmbH	NULL	Recruiting	18 Years	N/A	All	210	Phase 3	United States;Georgia;Italy;Poland;Romania

臨床試験数 : 175 / 薬物数 : 161 - (DrugBank : 41) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 24

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05581199 (ClinicalTrials.gov)	December 15, 2022	12/10/2022	To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDP	A Phase 2b, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study of BatoclimabTreatme ...	Chronic Inflammatory Demyelinating Polyneuropathy	Drug: Batoclimab680 milligrams (mg) subcutaneous (SC) weekly;Drug: Batoclimab340 mg SC weekly;Drug: ...	Immunovant Sciences GmbH	NULL	Recruiting	18 Years	N/A	All	240	Phase 2	United States